Showing results (11-20 of 151) with videos related to
Sort By:
Pageof 16
The FEBS Journal|January 15, 2011
TNFR1-induced activation of the classical NF-κB pathwayHarald Wajant, Peter ScheurichFrontiers in Cell and Developmental Biology|June 14, 2019
TNFR1 and TNFR2 in the Control of the Life and Death Balance of MacrophagesHarald Wajant, Daniela SiegmundAdvances in Experimental Medicine and Biology|September 18, 2009
The role of FasL and Fas in health and diseaseMartin Ehrenschwender, Harald WajantFrontiers in Cell and Developmental Biology|March 1, 2021
Receptor Oligomerization and Its Relevance for Signaling by Receptors of the Tumor Necrosis Factor Receptor SuperfamilyKirstin Kucka, Harald WajantFrontiers in Immunology|September 27, 2019
Targeting Regulatory T Cells by Addressing Tumor Necrosis Factor and Its Receptors in Allogeneic Hematopoietic Cell Transplantation and CancerHarald Wajant, Andreas BeilhackEuropean Journal of Biochemistry|February 22, 2002
Characterization and synthetic applications of recombinant AtNIT1 from Arabidopsis thalianaHarald Wajant, Franz EffenbergerMethods in Molecular Biology (Clifton, N.J.)|November 13, 2020
Analysis of FcγR-Dependent Agonism of Antibodies Specific for Receptors of the Tumor Necrosis Factor (TNF) Receptor Superfamily (TNFRSF)Juliane Medler, Harald WajantNature Reviews. Rheumatology|August 4, 2023
TNF and TNF receptors as therapeutic targets for rheumatic diseases and beyondDaniela Siegmund, Harald WajantExpert Opinion on Therapeutic Targets|March 12, 2019
Tumor necrosis factor receptor-2 (TNFR2): an overview of an emerging drug targetJuliane Medler, Harald WajantJournal of Leukocyte Biology|January 6, 2026
TNFR2-targeting biologics: Molecular mode of action, possible applications and future developmentsOlena Zaitseva, Harald WajantPageof 16